Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells